USA & Canada

Aspen Pharmacare Canada was founded in 2014 to support our products distributed in this region. The development of our complex API capabilities into niche FDF offerings represents an opportunity for future product launches in the United States. Our satellite API facility in Sioux City supports the Oss site in supplying APIs worldwide.

Key Countries

Canada
USA

Contribution to Group revenue

Revenue contribution - by therapeutic category

The Canadian pharmaceutical sector grew 7,8% and was valued at USD21 billion as at 31 December 2017.
The value of the US pharmaceutical sector grew 1,9% in 2017 while volumes declined 1,1%

Source: December 2018 IMS

STATISTICS

Number of products launched:

1

(2017: 3)

IMS value of pipeline as at 30 June 2018 anticipated to be launched in:

0 – 2 years

USD449 million

3 – 5 years

USD1 522 million

Number of product recalls:

Nil

(2017: nil)

Average staff turnover:

25,4%

(2017: 24,1%)

Number of work-related fatalities:

Nil

(2017: nil)

Number of permanent employees:

Revenue – R’billion	2018	2017 (CER)	% change
Total	561	1 001	(44)
Regional Brands	113	442	(74)
Anaesthetics	304	251	21
Thrombosis	8	15	(47)
High Potency & Cytotoxics	136	293	(54)